𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer

Book ID
121975756
Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
159 KB
Volume
7
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II study of tiazofurin (NSC 286193
Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinoma
✍ Paul Y. Holoye; David T. Carr; Hari M. Dhingra; Bonnie S. Glisson; Jin S. Lee; W πŸ“‚ Article πŸ“… 1988 πŸ› Springer US 🌐 English βš– 115 KB

Fourteen evaluable patients with small cell bronchogenic carcinoma received tiazofurin, an inhibitor of inosine monophosphate dehydrogenase, that progressed after one combination chemotherapy. No objective remission was observed at the dosage of 800 mg/m2 for 5 consecutive days. Toxicity was moderat

Phase II study of N-methylformamide, spi
Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): An Eastern cooperative oncology group study
✍ Ettinger, David S. ;Finkelstein, Dianne M. ;Donehower, Ross C. ;Chang, Alex Y. C πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 407 KB

One hundred forty-four patients with non-small cell lung cancer, the majority (72%) of whom had received previous chemotherapy, were evaluable in this randomized phase II study of N-methylformamide (N-MF), spirogermanium, and 4-demethoxydaunorubicin. There were two partial responses, one each with s